Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
AUSTIN, Texas, Nov. 8 /PRNewswire-FirstCall/ -- Encore Medical Corporation announced today that it has acquired Cefar AB, a leading European provider of electrotherapy and rehabilitation...
AUSTIN, Texas, Nov. 3 /PRNewswire-FirstCall/ -- Encore Medical Corporation (NASDAQ:ENMC) ("Encore") today announced that it had completed its going private transaction through a merger with a...
AUSTIN, Texas, Nov. 2 /PRNewswire-FirstCall/ -- Encore Medical Corporation ("Encore") (NASDAQ:ENMC) today announced that at a special meeting of its stockholders, its stockholders voted to adopt...
AUSTIN, Texas, Oct. 27 /PRNewswire-FirstCall/ -- Encore Medical Corporation (NASDAQ:ENMC) ("Encore") announced today the determination of the pricing for its previously announced tender offer to...
AUSTIN, Texas, Oct. 26 /PRNewswire-FirstCall/ -- Encore Medical Corporation (NASDAQ:ENMC) ("Encore") today announced its financial results for its third quarter ended September 30, 2006...
AUSTIN, Texas, Oct. 17 /PRNewswire-FirstCall/ -- Encore Medical Corporation (NASDAQ:ENMC) today announced preliminary unaudited financial results from continuing operations for its third quarter...
AUSTIN, Texas, Oct. 13 /PRNewswire-FirstCall/ -- Encore Medical Corporation (NASDAQ:ENMC) ("Encore") announced today that it had commenced a cash tender offer to purchase any and all of the...
AUSTIN, Texas, Oct. 12 /PRNewswire-FirstCall/ -- Encore Medical Corporation (NASDAQ:ENMC) announced today that the Company will release third quarter 2006 financial results prior to the opening...
AUSTIN, Texas, Sept. 25 /PRNewswire-FirstCall/ -- Encore Medical Corporation (NASDAQ:ENMC) ("Encore") announced today that, effective October 1, 2006, Peter W. Baird will join Encore as Group...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
